Takeda Pharmaceutical Company Limited Other Current Liabilities
Takeda Pharmaceutical Company Limited (TAK) had Other Current Liabilities of JPY 596.28 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:OtherCurrentLiabilities · last filed 2025-06-25
- 2025-03-31: Other Current Liabilities 596.28B JPY.
- 2024-03-31: Other Current Liabilities 619.17B JPY.
- 2023-03-31: Other Current Liabilities 566.69B JPY.
- 2022-03-31: Other Current Liabilities 584.95B JPY.
| Period end | Other Current Liabilities | Other Current Liabilities as first filed |
|---|---|---|
| 2025-03-31 | 596.28B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 619.17B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 566.69B JPY 20-F · filed 2024-06-26 | |
| 2022-03-31 | 584.95B JPY 20-F · filed 2023-06-28 | |
| 2021-03-31 | 542.65B JPY 20-F · filed 2022-06-29 | |
| 2020-03-31 | 499.39B JPY 20-F · filed 2021-06-29 | |
| 2019-03-31 | 439.06B JPY 20-F · filed 2020-06-24 | 437.89B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 263.93B JPY 20-F · filed 2019-06-27 |